Showing 661 - 680 results of 6,525 for search '"cardiovascular"', query time: 0.08s Refine Results
  1. 661

    The Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Obese Children and Adolescents in Dalmatia: A Hospital Based Study by Marko Šimunović, Joško Božić, Lukrecija Milić, Ivana Unić, Veselin Škrabić

    Published 2016-01-01
    “…The objectives of this study were to determine the prevalence of individual cardiovascular risk factors and MS. Between January 2009 and June 2014, 201 obese subjects aged 6 to 18 were analyzed retrospectively from our Pediatric Endocrine Unit database. …”
    Get full text
    Article
  2. 662

    Perceptions of Cardiovascular Healthcare Professionals Regarding Clinical Trials: A Survey-Based Study from the Middle East by Zainab Atiyah Dakhil, Hasan Ali Farhan, Mohammed Dheyaa Marsool, Mohammed Saad Qasim, Michele Peters, Jose Leal

    Published 2025-01-01
    “…Background: Low-middle income countries harbor the highest burden of cardiovascular diseases globally, but there is an under-representation of these countries in cardiovascular clinical trials. …”
    Get full text
    Article
  3. 663

    Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity by Xue Zhao, Wenyan Duan, Chenglin Sun, Zhuo Li, Yujia Liu, Xianchao Xiao, Gang Wang, Xiaokun Gang, Guixia Wang

    Published 2017-01-01
    “…The influence of bariatric surgery on cardiovascular risks in Chinese diabetic patients remains unclear. …”
    Get full text
    Article
  4. 664
  5. 665
  6. 666

    Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk by Klisic Aleksandra, Gluscevic Sanja, Karakasis Paschalis, Kotur-Stevuljevic Jelena, Ninic Ana

    Published 2025-01-01
    “…Background: The clinical utility of galectin-3 and fibroblast growth factor 23 (FGF-23) needs to be further explored since previous studies show divergent results in relation to type 2 diabetes (T2D) and cardiovascular risk. Hence, the aim of this research was to explore galectin-3 and FGF-23 in relation to T2D, as well as to examine the potential association of these biomarkers with atherosclerotic cardiovascular disease (ASCVD) risk score in Montenegrin adults. …”
    Get full text
    Article
  7. 667
  8. 668

    Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk by Andreas Pasch, Willi Jahnen-Dechent, Edward R. Smith

    Published 2018-01-01
    “…Phosphate is an important cardiovascular risk factor and lowering elevated blood phosphate concentrations is a main therapeutic target in kidney patients. …”
    Get full text
    Article
  9. 669

    Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution by Jeroen P. H. van Wijk, Manuel Castro Cabezas

    Published 2012-01-01
    “…However, mortality due to non-AIDS conditions, particularly cardiovascular disease (CVD) seems to increase in this population. …”
    Get full text
    Article
  10. 670

    Sociodemographic index–age differences in the global prevalence of cardiovascular diseases, 1990–2019: a population-based study by Xunliang Li, Channa Zhao, Mengqian Liu, Wenman Zhao, Haifeng Pan, Deguang Wang

    Published 2025-01-01
    “…Abstract Background This study aims to assess the global burden and trends in cardiovascular diseases (CVDs) prevalence, stratified by sociodemographic index (SDI) categories and age groups, across 204 countries and territories. …”
    Get full text
    Article
  11. 671

    Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates. by Mira T Keddis, Ziad El-Zoghby, Bruce Kaplan, Jeffrey W Meeusen, Leslie J Donato, Fernando G Cosio, D Eric Steidley

    Published 2017-01-01
    “…<h4>Background</h4>Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure. …”
    Get full text
    Article
  12. 672

    Circulatory physiology : the essentials / by Smith, James J. (James John), 1914-

    Published 1990
    Subjects: “…Cardiovascular system. 128…”
    View in OPAC
    Book
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680